Primary Site >> Biliary tract Cancer

Gene >> IDH1

Journal: Oncologist. 2012;17(1):72-9.
Title: Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping.
Author: Borger, Darrell R|Tanabe, Kenneth K|Fan, Kenneth C|Lopez, Hector U|Fantin, Valeria R|Straley, Kimberly S|Schenkein, David P|Hezel, Aram F|Ancukiewicz, Marek|Liebman, Hannah M|Kwak, Eunice L|Clark, Jeffrey W|Ryan, David P|Deshpande, Vikram|Dias-Santagata,
PMID: 22180306
Journal: Oncogene. 2013 Jun 20;32(25):3091-100.
Title: Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.
Author: Wang, P|Dong, Q|Zhang, C|Kuan, P-F|Liu, Y|Jeck, W R|Andersen, J B|Jiang, W|Savich, G L|Tan, T-X|Auman, J T|Hoskins, J M|Misher, A D|Moser, C D|Yourstone, S M|Kim, J W|Cibulskis, K|Getz, G|Hunt, H V|Thorgeirsson, S S|Roberts, L R|Ye, D|Guan, K-L|Xiong, Y|Q
PMID: 22824796
Journal: Oncogene. 2013 Oct 10;32(41):4861-70.
Title: Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies.
Author: Sia, D|Tovar, V|Moeini, A|Llovet, J M
PMID: 23318457
Journal: Hum Pathol. 2013 Jul;44(7):1216-22.
Title: Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions.
Author: Voss, Jesse S|Holtegaard, Leonard M|Kerr, Sarah E|Fritcher, Emily G Barr|Roberts, Lewis R|Gores, Gregory J|Zhang, Jun|Highsmith, W Edward|Halling, Kevin C|Kipp, Benjamin R
PMID: 23391413
Journal: Nat Genet. 2013 Dec;45(12):1474-8.
Title: Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers.
Author: Chan-On, Waraporn|Nairismagi, Maarja-Liisa|Ong, Choon Kiat|Lim, Weng Khong|Dima, Simona|Pairojkul, Chawalit|Lim, Kiat Hon|McPherson, John R|Cutcutache, Ioana|Heng, Hong Lee|Ooi, London|Chung, Alexander|Chow, Pierce|Cheow, Peng Chung|Lee, Ser Yee|Choo, Su
PMID: 24185513
Journal: Biochim Biophys Acta. 2014 Dec;1846(2):326-41.
Title: The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation.
Author: Molenaar, Remco J|Radivoyevitch, Tomas|Maciejewski, Jaroslaw P|van Noorden, Cornelis J F|Bleeker, Fonnet E
PMID: 24880135
Journal: PLoS One. 2014 Dec 23;9(12):e115383.
Title: Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
Author: Churi, Chaitanya R|Shroff, Rachna|Wang, Ying|Rashid, Asif|Kang, HyunSeon C|Weatherly, Jacqueline|Zuo, Mingxin|Zinner, Ralph|Hong, David|Meric-Bernstam, Funda|Janku, Filip|Crane, Christopher H|Mishra, Lopa|Vauthey, Jean-Nicholas|Wolff, Robert A|Mills, Gord
PMID: 25536104
Journal: Nat Commun. 2014 Dec 15;5:5696.
Title: Mutational landscape of intrahepatic cholangiocarcinoma.
Author: Zou, Shanshan|Li, Jiarui|Zhou, Huabang|Frech, Christian|Jiang, Xiaolan|Chu, Jeffrey S C|Zhao, Xinyin|Li, Yuqiong|Li, Qiaomei|Wang, Hui|Hu, Jingyi|Kong, Guanyi|Wu, Mengchao|Ding, Chuanfan|Chen, Nansheng|Hu, Heping
PMID: 25526346
Journal: Cell Cycle. 2014;13(20):3176-82.
Title: IDH mutations in liver cell plasticity and biliary cancer.
Author: Saha, Supriya K|Parachoniak, Christine A|Bardeesy, Nabeel
PMID: 25485496
Journal: Semin Liver Dis. 2014 Nov;34(4):456-64.
Title: Cholangiocarcinoma: molecular pathways and therapeutic opportunities.
Author: Rizvi, Sumera|Borad, Mitesh J|Patel, Tushar|Gores, Gregory J
PMID: 25369307
Journal: Nature. 2014 Sep 4;513(7516):110-4.
Title: Mutant IDH inhibits HNF-4alpha to block hepatocyte differentiation and promote biliary cancer.
Author: Saha, Supriya K|Parachoniak, Christine A|Ghanta, Krishna S|Fitamant, Julien|Ross, Kenneth N|Najem, Mortada S|Gurumurthy, Sushma|Akbay, Esra A|Sia, Daniela|Cornella, Helena|Miltiadous, Oriana|Walesky, Chad|Deshpande, Vikram|Zhu, Andrew X|Hezel, Aram F|Yen,
PMID: 25043045
Journal: Ann Surg Oncol. 2014 Nov;21(12):3827-34.
Title: Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets.
Author: Zhu, Andrew X|Borger, Darrell R|Kim, Yuhree|Cosgrove, David|Ejaz, Aslam|Alexandrescu, Sorin|Groeschl, Ryan Thomas|Deshpande, Vikram|Lindberg, James M|Ferrone, Cristina|Sempoux, Christine|Yau, Thomas|Poon, Ronnie|Popescu, Irinel|Bauer, Todd W|Gamblin, T Cl
PMID: 24889489
Journal: Curr Opin Gastroenterol. 2014 May;30(3):295-302.
Title: Mutations of isocitrate dehydrogenase 1 and 2 in intrahepatic cholangiocarcinoma.
Author: Grassian, Alexandra R|Pagliarini, Raymond|Chiang, Derek Y
PMID: 24569570
Journal: Oncologist. 2014 Mar;19(3):235-42.
Title: New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.
Author: Ross, Jeffrey S|Wang, Kai|Gay, Laurie|Al-Rohil, Rami|Rand, Janne V|Jones, David M|Lee, Hwa J|Sheehan, Christine E|Otto, Geoff A|Palmer, Gary|Yelensky, Roman|Lipson, Doron|Morosini, Deborah|Hawryluk, Matthew|Catenacci, Daniel V T|Miller, Vincent A|Churi, C
PMID: 24563076
Journal: J Hepatobiliary Pancreat Sci. 2014 Jun;21(6):380-7.
Title: Genomic and transcriptional alterations of cholangiocarcinoma.
Author: Ito, Takeshi|Sakurai-Yageta, Mika|Goto, Akiteru|Pairojkul, Chawalit|Yongvanit, Puangrat|Murakami, Yoshinori
PMID: 24532422
Journal: Clin Cancer Res. 2014 Apr 1;20(7):1884-90.
Title: Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma.
Author: Borger, Darrell R|Goyal, Lipika|Yau, Thomas|Poon, Ronnie T|Ancukiewicz, Marek|Deshpande, Vikram|Christiani, David C|Liebman, Hannah M|Yang, Hua|Kim, Hyeryun|Yen, Katharine|Faris, Jason E|Iafrate, A John|Kwak, Eunice L|Clark, Jeffrey W|Allen, Jill N|Blaszk
PMID: 24478380
Journal: Mod Pathol. 2014 Aug;27(8):1163-73.
Title: Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.
Author: Liau, Jau-Yu|Tsai, Jia-Huei|Yuan, Ray-Hwang|Chang, Chih-Ning|Lee, Hsin-Jung|Jeng, Yung-Ming
PMID: 24406866
Journal: Oncologist. 2015 Sep;20(9):1019-27.
Title: Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma.
Author: Goyal, Lipika|Govindan, Aparna|Sheth, Rahul A|Nardi, Valentina|Blaszkowsky, Lawrence S|Faris, Jason E|Clark, Jeffrey W|Ryan, David P|Kwak, Eunice L|Allen, Jill N|Murphy, Janet E|Saha, Supriya K|Hong, Theodore S|Wo, Jennifer Y|Ferrone, Cristina R|Tanabe, K
PMID: 26245674
Journal: Asian Pac J Cancer Prev. 2015;16(14):5875-81.
Title: Altered Expression of Oxidative Metabolism Related Genes in Cholangiocarcinomas.
Author: Aukkanimart, Ratchadawan|Boonmars, Thidarut|Juasook, Amornrat|Sriraj, Pranee|Boonjaraspinyo, Sirintip|Wu, Zhiliang|Laummuanwai, Porntip|Pairojkul, Chawalit|Khuntikeo, Narong|Rattanasuwan, Panaratana
PMID: 26320466
Journal: Exp Mol Pathol. 2015 Oct;99(2):344-53.
Title: Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay.
Author: Arnold, Alexander|Bahra, Marcus|Lenze, Dido|Bradtmoller, Maren|Guse, Katrin|Gehlhaar, Claire|Blaker, Hendrik|Heppner, Frank L|Koch, Arend
PMID: 26260902
Journal: Exp Mol Pathol. 2015 Oct;99(2):240-4.
Title: Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing.
Author: Putra, Juan|de Abreu, Francine B|Peterson, Jason D|Pipas, J Marc|Mody, Kabir|Amos, Christopher I|Tsongalis, Gregory J|Suriawinata, Arief A
PMID: 26189129
Journal: Nat Commun. 2015 Jan 30;6:6120.
Title: Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity.
Author: Fujimoto, Akihiro|Furuta, Mayuko|Shiraishi, Yuichi|Gotoh, Kunihito|Kawakami, Yoshiiku|Arihiro, Koji|Nakamura, Toru|Ueno, Masaki|Ariizumi, Shun-ichi|Nguyen, Ha Hai|Shigemizu, Daichi|Abe, Tetsuo|Boroevich, Keith A|Nakano, Kaoru|Sasaki, Aya|Kitada, Rina|Maej
PMID: 25636086
Journal: J Hepatobiliary Pancreat Sci. 2015 Feb;22(2):114-23.
Title: Molecular diagnosis of intrahepatic cholangiocarcinoma.
Author: Haga, Hiroaki|Patel, Tushar
PMID: 25267595
Journal: Nat Commun. 2015 Jan 22;6:6087.
Title: Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma.
Author: Sia, Daniela|Losic, Bojan|Moeini, Agrin|Cabellos, Laia|Hao, Ke|Revill, Kate|Bonal, Dennis|Miltiadous, Oriana|Zhang, Zhongyang|Hoshida, Yujin|Cornella, Helena|Castillo-Martin, Mireia|Pinyol, Roser|Kasai, Yumi|Roayaie, Sasan|Thung, Swan N|Fuster, Josep|Schw
PMID: 25608663
Journal: Hum Pathol. 2015 Feb;46(2):322-6.
Title: Increased plasma d-2-hydroxyglutarate in isocitrate dehydrogenase 2-mutated blastic plasmacytoid dendritic cell neoplasm.
Author: Rakheja, Dinesh|Fuda, Franklin|Vandergriff, Travis|Boriack, Richard|Medeiros, Bruno C|Frankel, Arthur E|Chen, Weina
PMID: 25481493
Journal: Mod Pathol. 2015 Sep;28(9):1249-64.
Title: Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases.
Author: Schlitter, Anna Melissa|Jang, Kee-Taek|Kloppel, Gunter|Saka, Burcu|Hong, Seung-Mo|Choi, Hyejeong|Offerhaus, George Johan|Hruban, Ralph H|Zen, Yoh|Konukiewitz, Bjorn|Regel, Ivonne|Allgauer, Michael|Balci, Serdar|Basturk, Olca|Reid, Michelle D|Esposito, Ire
PMID: 26111977
Journal: Pathol Int. 2016 Oct;66(10):578-582.
Title: Immunohistochemistry using monoclonal antibody MsMab-2 is useful to detect IDH1 R132L in intrahepatic cholangiocarcinoma.
Author: Hayashi, Akimasa|Misumi, Kento|Shibahara, Junji|Kokudo, Norihiro|Kato, Yukinari|Fukayama, Masashi
PMID: 27595804
Journal: J Gastrointest Oncol. 2016 Dec;7(6):E98-E102.
Title: Impressive response to dual BRAF and MEK inhibition in patients with BRAF mutant intrahepatic cholangiocarcinoma-2 case reports and a brief review.
Author: Lavingia, Viraj|Fakih, Marwan
PMID: 28078132
Journal: Chin Clin Oncol. 2016 Oct;5(5):65.
Title: Systemic therapy for biliary cancers.
Author: Jordan, Emmet|Abou-Alfa, Ghassan K|Lowery, Maeve A
PMID: 27829278
Journal: J Gastrointest Oncol. 2016 Oct;7(5):797-803.
Title: Molecular profiling of biliary tract cancer: a target rich disease.
Author: Jain, Apurva|Javle, Milind
PMID: 27747093
Journal: Cancer. 2016 Dec 15;122(24):3838-3847.
Title: Biliary cancer: Utility of next-generation sequencing for clinical management.
Author: Javle, Milind|Bekaii-Saab, Tanios|Jain, Apurva|Wang, Ying|Kelley, Robin Katie|Wang, Kai|Kang, Hyunseon C|Catenacci, Daniel|Ali, Siraj|Krishnan, Sunil|Ahn, Daniel|Bocobo, Andrea Grace|Zuo, Mingxin|Kaseb, Ahmed|Miller, Vincent|Stephens, Philip J|Meric-Berns
PMID: 27622582
Journal: J Blood Med. 2016 Sep 2;7:171-80.
Title: IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives.
Author: Mondesir, Johanna|Willekens, Christophe|Touat, Mehdi|de Botton, Stephane
PMID: 27621679
Journal: Cancer Discov. 2016 Jul;6(7):727-39.
Title: Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma.
Author: Saha, Supriya K|Gordan, John D|Kleinstiver, Benjamin P|Vu, Phuong|Najem, Mortada S|Yeo, Jia-Chi|Shi, Lei|Kato, Yasutaka|Levin, Rebecca S|Webber, James T|Damon, Leah J|Egan, Regina K|Greninger, Patricia|McDermott, Ultan|Garnett, Mathew J|Jenkins, Roger L|R
PMID: 27231123
Journal: Oncotarget. 2016 Jul 19;7(29):46750-46767.
Title: The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets.
Author: Chong, Dawn Q|Zhu, Andrew X
PMID: 27102149
Journal: BMC Res Notes. 2016 Feb 27;9:126.
Title: Maffucci syndrome and neoplasms: a case report and review of the literature.
Author: Prokopchuk, Olga|Andres, Stephanie|Becker, Karen|Holzapfel, Konstantin|Hartmann, Daniel|Friess, Helmut
PMID: 26920730
Journal: Clin Cancer Res. 2016 Apr 15;22(8):1837-42.
Title: Molecular Pathways: Isocitrate Dehydrogenase Mutations in Cancer.
Author: Clark, Owen|Yen, Katharine|Mellinghoff, Ingo K
PMID: 26819452
Journal: Ann Surg Oncol. 2016 May;23(5):1699-707.
Title: Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
Author: Ruzzenente, Andrea|Fassan, Matteo|Conci, Simone|Simbolo, Michele|Lawlor, Rita T|Pedrazzani, Corrado|Capelli, Paola|D'Onofrio, Mirko|Iacono, Calogero|Scarpa, Aldo|Guglielmi, Alfredo
PMID: 26717940
Journal: J Clin Pathol. 2016 May;69(5):403-8.
Title: Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targets.
Author: Lee, Hwajeong|Wang, Kai|Johnson, Adrienne|Jones, David M|Ali, Siraj M|Elvin, Julia A|Yelensky, Roman|Lipson, Doron|Miller, Vincent A|Stephens, Philip J|Javle, Milind|Ross, Jeffrey S
PMID: 26500333
Journal: Clin Cancer Res. 2016 Jan 15;22(2):291-300.
Title: Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma.
Author: Moeini, Agrin|Sia, Daniela|Bardeesy, Nabeel|Mazzaferro, Vincenzo|Llovet, Josep M
PMID: 26405193
Journal: Histopathology. 2017 Apr;70(5):766-774.
Title: Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 loss.
Author: Misumi, Kento|Hayashi, Akimasa|Shibahara, Junji|Arita, Junichi|Sakamoto, Yoshihiro|Hasegawa, Kiyoshi|Kokudo, Norihiro|Fukayama, Masashi
PMID: 27864835
Journal: Cancer Control. 2017 Jul-Sep;24(3):1073274817729241.
Title: Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma.
Author: Chun, Yun Shin|Javle, Milind
PMID: 28975832
Journal: Cancer Discov. 2017 Sep;7(9):943-962.
Title: New Horizons for Precision Medicine in Biliary Tract Cancers.
Author: Valle, Juan W|Lamarca, Angela|Goyal, Lipika|Barriuso, Jorge|Zhu, Andrew X
PMID: 28818953
Journal: J Gastrointest Oncol. 2017 Jun;8(3):430-440.
Title: Current biologics for treatment of biliary tract cancers.
Author: Zhao, Diana Y|Lim, Kian-Huat
PMID: 28736630
Journal: BMJ Open. 2017 Jun 10;7(6):e014961.
Title: Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours.
Author: Molenaar, Remco J|Coelen, Robert J S|Khurshed, Mohammed|Roos, Eva|Caan, Matthan W A|van Linde, Myra E|Kouwenhoven, Mathilde|Bramer, Jos A M|Bovee, Judith V M G|Mathot, Ron A|Klumpen, Heinz-Josef|van Laarhoven, Hanneke W M|van Noorden, Cornelis J F|Vandert
PMID: 28601826
Journal: Therap Adv Gastroenterol. 2017 Jun;10(6):507-520.
Title: The potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancer.
Author: Lee, Hwajeong|Ross, Jeffrey S
PMID: 28567120
Journal: Hum Pathol. 2017 Jun;64:118-127.
Title: Clinicopathological, radiologic, and molecular study of 23 combined hepatocellular-cholangiocarcinomas with stem cell features, cholangiolocellular type.
Author: Chen, Jun|He, Jian|Deng, Min|Wu, Hong-Yan|Shi, Jiong|Mao, Liang|Sun, Qi|Tang, Min|Fan, Xiang-Shan|Qiu, Yu-Dong|Huang, Qin
PMID: 28431889
Journal: J Hepatol. 2017 Sep;67(3):632-644.
Title: Emerging molecular therapeutic targets for cholangiocarcinoma.
Author: Rizvi, Sumera|Gores, Gregory J
PMID: 28389139
Journal: Annu Rev Biochem. 2017 Jun 20;86:305-331.
Title: Isocitrate Dehydrogenase Mutation and (R)-2-Hydroxyglutarate: From Basic Discovery to Therapeutics Development.
Author: Dang, Lenny|Su, Shin-San Michael
PMID: 28375741
Journal: Mod Pathol. 2017 Jul;30(7):986-997.
Title: Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas.
Author: Akita, Masayuki|Fujikura, Kohei|Ajiki, Tetsuo|Fukumoto, Takumi|Otani, Kyoko|Azuma, Takeshi|Itoh, Tomoo|Ku, Yonson|Zen, Yoh
PMID: 28338651
Journal: Cell Rep. 2017 Mar 14;18(11):2780-2794.
Title: Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.
Author: Farshidfar, Farshad|Zheng, Siyuan|Gingras, Marie-Claude|Newton, Yulia|Shih, Juliann|Robertson, A Gordon|Hinoue, Toshinori|Hoadley, Katherine A|Gibb, Ewan A|Roszik, Jason|Covington, Kyle R|Wu, Chia-Chin|Shinbrot, Eve|Stransky, Nicolas|Hegde, Apurva|Yang, J
PMID: 28297679
Journal: Acta Neuropathol. 2017 Apr;133(4):629-644.
Title: Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo.
Author: Pusch, Stefan|Krausert, Sonja|Fischer, Viktoria|Balss, Jorg|Ott, Martina|Schrimpf, Daniel|Capper, David|Sahm, Felix|Eisel, Jessica|Beck, Ann-Christin|Jugold, Manfred|Eichwald, Viktoria|Kaulfuss, Stefan|Panknin, Olaf|Rehwinkel, Hartmut|Zimmermann, Katja|Hi
PMID: 28124097
Journal: World J Surg Oncol. 2017 Apr 12;15(1):82.
Title: IDH1 R132C mutation is detected in clear cell hepatocellular carcinoma by pyrosequencing.
Author: Lee, Jung Hee|Shin, Dong Hoon|Park, Won Young|Shin, Nari|Kim, Ahrong|Lee, Hyun Jung|Kim, Young Keum|Choi, Kyung Un|Kim, Jee Yeon|Yang, Young Il|Lee, Chang Hun|Sol, Mee Young
PMID: 28403884
Journal: Hum Pathol. 2018 Aug;78:131-137.
Title: Mucinous intrahepatic cholangiocarcinoma: a distinct variant.
Author: Chi, Zhikai|Bhalla, Amarpreet|Saeed, Omer|Cheng, Liang|Curless, Kendra|Wang, Hanlin L|Patil, Deepa T|Lin, Jingmei
PMID: 29698701
Journal: Oncologist. 2018 Oct 23. pii: theoncologist.2018-0210.
Title: A Case of Metastatic Biliary Tract Cancer Diagnosed Through Identification of an IDH1 Mutation.
Author: Kamath, Suneel Deepak|Lin, Xiaoqi|Kalyan, Aparna
PMID: 30352944
Journal: Cancer Lett. 2018 Aug 10;429:1-10.
Title: Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation.
Author: Huang, Chiung-Kuei|Iwagami, Yoshifumi|Zou, Jing|Casulli, Sarah|Lu, Shaolei|Nagaoka, Katsuya|Ji, Chengcheng|Ogawa, Kousuke|Cao, Kevin Y|Gao, Jin-Song|Carlson, Rolf I|Wands, Jack R
PMID: 29733964
Journal: Clin Lab Med. 2018 Jun;38(2):367-384.
Title: Molecular Diagnostics in the Neoplasms of the Pancreas, Liver, Gallbladder, and Extrahepatic Biliary Tract: 2018 Update.
Author: Zhang, Lei|Bluth, Martin H|Bhalla, Amarpreet
PMID: 29776636
Journal: Clin Cancer Res. 2018 Sep 1;24(17):4154-4161.
Title: Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention.
Author: Lowery, Maeve A|Ptashkin, Ryan|Jordan, Emmet|Berger, Michael F|Zehir, Ahmet|Capanu, Marinela|Kemeny, Nancy E|O'Reilly, Eileen M|El-Dika, Imane|Jarnagin, William R|Harding, James J|D'Angelica, Michael I|Cercek, Andrea|Hechtman, Jaclyn F|Solit, David B|Schu
PMID: 29848569
Journal: BMC Genomics. 2018 Jun 5;19(1):440.
Title: Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma.
Author: Peraldo-Neia, C|Ostano, P|Cavalloni, G|Pignochino, Y|Sangiolo, D|De Cecco, L|Marchesi, E|Ribero, D|Scarpa, A|De Rose, A M|Giuliani, A|Calise, F|Raggi, C|Invernizzi, P|Aglietta, M|Chiorino, G|Leone, F
PMID: 29871612
Journal: Jpn J Clin Oncol. 2018 Aug 1;48(8):703-711.
Title: New developments in systemic therapy for advanced biliary tract cancer.
Author: Morizane, Chigusa|Ueno, Makoto|Ikeda, Masafumi|Okusaka, Takuji|Ishii, Hiroshi|Furuse, Junji
PMID: 29893894
Journal: Cancer Sci. 2018 Aug 28.
Title: Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1.
Author: Fujiwara, Hiroaki|Tateishi, Keisuke|Kato, Hiroyuki|Nakatsuka, Takuma|Yamamoto, Keisuke|Tanaka, Yasuo|Ijichi, Hideaki|Takahara, Naminatsu|Mizuno, Suguru|Kogure, Hirofumi|Matsubara, Saburo|Nakai, Yousuke|Koike, Kazuhiko
PMID: 30156013
Journal: Front Genet. 2018 Aug 15;9:309.
Title: Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type.
Author: Shiao, Meng-Shin|Chiablaem, Khajeelak|Charoensawan, Varodom|Ngamphaiboon, Nuttapong|Jinawath, Natini
PMID: 30158952
Journal: HPB (Oxford). 2018 Aug 28. pii: S1365-182X(18)32708-4.
Title: Histological and molecular characterization of intrahepatic bile duct cancers suggests an expanded definition of perihilar cholangiocarcinoma.
Author: Akita, Masayuki|Sofue, Keitaro|Fujikura, Kohei|Otani, Kyoko|Itoh, Tomoo|Ajiki, Tetsuo|Fukumoto, Takumi|Zen, Yoh
PMID: 30170977
Journal: Mod Pathol. 2018 Sep 11. pii: 10.1038/s41379-018-0126-3.
Title: The role of a monoclonal antibody 11C8B1 as a diagnostic marker of IDH2-mutated sinonasal undifferentiated carcinoma.
Author: Dogan, Snjezana|Frosina, Denise|Fayad, Miriam|de Oliveira, Thais Basili|Alemar, Barbara|Rosenblum, Marc|Tang, Laura H|Hameed, Meera|Xu, Bin|Ghossein, Ronald A|Chute, Deborah J|Weigelt, Britta|Jungbluth, Achim A
PMID: 30206411
Journal: Cancer Treat Rev. 2018 Sep 8;70:168-177.
Title: Biliary Tract Cancer: State of the Art and potential role of DNA Damage Repair.
Author: Lamarca, Angela|Barriuso, Jorge|McNamara, Mairead G|Valle, Juan W
PMID: 30218788
Journal: J Surg Res. 2018 Nov;231:116-125.
Title: IDH1 mutation correlates with a beneficial prognosis and suppresses tumor growth in IHCC.
Author: Wang, Jian|Zhang, Zhan-Guo|Ding, Ze-Yang|Dong, Wei|Liang, Hui-Fang|Chu, Liang|Zhang, Bi-Xiang|Chen, Xiao-Ping
PMID: 30278918
Journal: Cancer Sci. 2018 May;109(5):1282-1291.
Title: Molecular genomic landscapes of hepatobiliary cancer.
Author: Shibata, Tatsuhiro|Arai, Yasuhito|Totoki, Yasushi
PMID: 29573058
Journal: J Hepatol. 2018 Jul;69(1):89-98.
Title: Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
Author: Dong, Liang-Qing|Shi, Yang|Ma, Li-Jie|Yang, Liu-Xiao|Wang, Xiao-Ying|Zhang, Shu|Wang, Zhi-Chao|Duan, Meng|Zhang, Zhao|Liu, Long-Zi|Zheng, Bo-Hao|Ding, Zhen-Bin|Ke, Ai-Wu|Gao, Da-Ming|Yuan, Ke|Zhou, Jian|Fan, Jia|Xi, Ruibin|Gao, Qiang
PMID: 29551704
Journal: Abdom Radiol (NY). 2018 Oct;43(10):2665-2672.
Title: Intrahepatic cholangiocarcinoma: can imaging phenotypes predict survival and tumor genetics?
Author: Aherne, Emily A|Pak, Linda M|Goldman, Debra A|Gonen, Mithat|Jarnagin, William R|Simpson, Amber L|Do, Richard K
PMID: 29492607
Journal: Expert Opin Emerg Drugs. 2018 Mar;23(1):63-75.
Title: Emerging molecular target antagonists for the treatment of biliary tract cancer.
Author: Lombardi, Pasquale|Marino, Donatella|Fenocchio, Elisabetta|Chila, Giovanna|Aglietta, Massimo|Leone, Francesco
PMID: 29468924
Journal: Future Oncol. 2018 Mar;14(6):553-566.
Title: Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma.
Author: DeLeon, Thomas T|Ahn, Daniel H|Bogenberger, James M|Anastasiadis, Panos Z|Arora, Mansi|Ramanathan, Ramesh K|Aqel, Bashar A|Vasmatzis, George|Truty, Mark J|Oklu, Rahmi|Bekaii-Saab, Tanios S|Borad, Mitesh J
PMID: 29460642
Journal: Eur J Cancer. 2018 Mar;92:11-19.
Title: PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study.
Author: Vogel, Arndt|Kasper, Stefan|Bitzer, Michael|Block, Andreas|Sinn, Marianne|Schulze-Bergkamen, Henning|Moehler, Markus|Pfarr, Nicole|Endris, Volker|Goeppert, Benjamin|Merx, Kirsten|Schnoy, Elisabeth|Siveke, Jens T|Michl, Patrick|Waldschmidt, Dirk|Kuhlmann,
PMID: 29413685
Journal: Biochim Biophys Acta Mol Basis Dis. 2018 Jun;1864(6 Pt B):2360-2368.
Title: Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity.
Author: Liu, Zhen-Hao|Lian, Bao-Feng|Dong, Qiong-Zhu|Sun, Han|Wei, Jin-Wang|Sheng, Yuan-Yuan|Li, Wei|Li, Yi-Xue|Xie, Lu|Liu, Lei|Qin, Lun-Xiu
PMID: 29408647
Journal: Cancer Control. 2018 Jan-Mar;25(1):1073274817744658.
Title: Primary Liver Cancers, Part 2: Progression Pathways and Carcinogenesis.
Author: Jiang, Kun|Centeno, Barbara A
PMID: 29353494
Journal: Am J Surg Pathol. 2018 Apr;42(4):512-521.
Title: MDM2 Amplification in Intrahepatic Cholangiocarcinomas: Its Relationship With Large-Duct Type Morphology and Uncommon KRAS Mutations.
Author: Kim, Sung Joo|Akita, Masayuki|Sung, You-Na|Fujikura, Kohei|Lee, Jae Hoon|Hwang, Shin|Yu, Eunsil|Otani, Kyoko|Hong, Seung-Mo|Zen, Yoh
PMID: 29309301
Journal: Hepatology. 2018 Sep;68(3):949-963.
Title: Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma.
Author: Nepal, Chirag|O'Rourke, Colm J|Oliveira, Douglas V N P|Taranta, Andrzej|Shema, Steven|Gautam, Prson|Calderaro, Julien|Barbour, Andrew|Raggi, Chiara|Wennerberg, Krister|Wang, Xin W|Lautem, Anja|Roberts, Lewis R|Andersen, Jesper B
PMID: 29278425
Journal: Eur J Cancer. 2018 Feb;90:83-91.
Title: Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomas.
Author: Delahousse, Julia|Verlingue, Loic|Broutin, Sophie|Legoupil, Clemence|Touat, Mehdi|Doucet, Ludovic|Ammari, Samy|Lacroix, Ludovic|Ducreux, Michel|Scoazec, Jean-Yves|Malka, David|Paci, Angelo|Hollebecque, Antoine
PMID: 29274619
Journal: Gastroenterology. 2018 Mar;154(4):1066-1079.e5.
Title: MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma.
Author: Lampis, Andrea|Carotenuto, Pietro|Vlachogiannis, Georgios|Cascione, Luciano|Hedayat, Somaieh|Burke, Rosemary|Clarke, Paul|Bosma, Else|Simbolo, Michele|Scarpa, Aldo|Yu, Sijia|Cole, Rebecca|Smyth, Elizabeth|Mateos, Javier Fernandez|Begum, Ruwaida|Hezelova,
PMID: 29113809
Journal: Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1454-1460.
Title: Targeting cholangiocarcinoma.
Author: Mertens, Joachim C|Rizvi, Sumera|Gores, Gregory J
PMID: 28844952